Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.
äŒæ¥ã³ãŒãCTKB
äŒç€ŸåCytek Biosciences Inc
äžå Žæ¥Jul 23, 2021
æé«çµå¶è²¬ä»»è
ãCEOãJiang (Wenbin)
åŸæ¥å¡æ°648
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Jul 23
æ¬ç€Ÿæåšå°47215 Lakeview Boulevard
éœåžFREMONT
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·94538
é»è©±çªå·18779229835
ãŠã§ããµã€ãhttps://cytekbio.com
äŒæ¥ã³ãŒãCTKB
äžå Žæ¥Jul 23, 2021
æé«çµå¶è²¬ä»»è
ãCEOãJiang (Wenbin)